欢迎来到创赛优选商城 !
PBS磷酸盐缓冲液(20×) 三苯基硫氯甲烷,≥96% Regorafenib (BAY 73-4506) 1-氨基芘
DCPIB is an inhibitor of volume-regulated anion channels (VRAC).1 It inhibits the swelling-induced chloride current (ICl,swell) in bovine pulmonary artery endothelial cells (IC50 = 4.1 µM). DCPIB inhibits the VRAC subunit leucine-rich containing 8A (LRRC8A; IC50 = 20.9 µM) and inhibits sphingosine-1-phosphate-induced cGAMP uptake by LRRC8A in telomerase-immortalized human microvascular endothelial (TIME) cells when used at a concentration of 20 µM.2,3 It also inhibits the two-pore domain potassium channels K2P18.1/TRESK, K2P3.1/TASK1, and K2P9.1/TASK3 in COS-7 cells expressing the human channels (IC50s = 0.14, 0.95, and 50.72 µM, respectively).4 DCPIB (10 µM) activates K2P2.1/TREK1 and K2P4.1/TRAAK channels in COS-7 cells expressing the human channels. Intracisternal administration of DCPIB (20 µg/kg) reduces infarct area and neurological deficit scores in a rat model of cerebral ischemia induced by middle cerebral artery occlusion (MCAO).5
WARNING This product is not for human or veterinary use.
Please login or provide user information below. Please use your company email address.
创赛客服1
创赛客服2
创赛客服3
创赛客服4
400-608-7598